“High Sensitivity Versus Low Level of Vancomycin Needs to Be Concern for Another Alternative Anti- Staphylococcus Aureus As the First- Line Antibiotic”. Acta Biomedica Atenei Parmensis, vol. 90, no. 4, Dec. 2019, pp. 498-03, https://doi.org/10.23750/abm.v90i4.7646.